Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon
Open Access
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (12) , 1067-1074
- https://doi.org/10.1111/j.1469-0691.2004.01023.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hematologic Disorders Associated with Hepatitis C Virus Infection and Their ManagementClinical Infectious Diseases, 2003
- Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency VirusClinical Infectious Diseases, 2003
- Side effects of therapy of hepatitis C and their managementHepatology, 2002
- Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CHepatology, 2002
- Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus ConferenceHIV Research & Clinical Practice, 2002
- Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patientsAIDS, 2001
- Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patientsAIDS, 2000
- Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosisJournal of Hepatology, 1997
- Influence of Interferon-α on Cytokine Expression by the Bone Marrow Microenvironment—Impact on Treatment of Myeloproliferative DisordersLeukemia & Lymphoma, 1996
- Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired Hepatitis CEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995